G67C (p.Gly67Cys) variant of KRT16 (Keratin, type I cytoskeletal 16)

G67C (p.Gly67Cys) in KRT16 (Keratin, type I cytoskeletal 16) is a missense change. Clinical records from EBI and UniProt describe it as benign. The available variant effect predictions contribute to a CATVariant prioritization score of 0.36 / 1. The record also includes population frequency data and structural context.

G67C (p.Gly67Cys) variant details